Bruker
Bruker Corp is an American scientific instruments manufacturer engaged in the design, development, and high-volume production of advanced analytical equipment and diagnostic solutions. The company produces nuclear magnetic resonance spectrometers, mass spectrometers, X-ray analytical instruments, atomic force microscopes, and molecular diagnostic platforms. Its high-precision analytical hardware supports life science research, biopharmaceutical drug discovery, materials analysis, industrial quality control, and clinical microbiology laboratories globally. Principal revenue is derived from direct commercial equipment sales of scientific instruments, consumable software licenses, spare parts distribution, and comprehensive equipment maintenance service agreements. Bruker holds a market-leading position in nuclear magnetic resonance spectroscopy and mass spectrometry hardware for scientific research. Headquartered in Billerica, Massachusetts, the company's common stock is publicly listed and traded on the Nasdaq Global Select Market under the ticker BRKR.
5 of the funds FundTelligence covers report a position in Bruker.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 5
Funds holding Bruker
- DNB Health Care — DNB · 0.65 % (full portfolio disclosed, September 2026)
- Handelsbanken Infrastruktur och Beredskap — Handelsbanken · 0.29 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.1 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.06 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.06 % (partially disclosed portfolio, June 2026)